BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 6180172)

  • 21. [Research on the detoxifying effects of certain chelating agents after poisoning of the isolated rabbit kidney by mercury salts].
    Truhaut R; Boudènce C; Jouany JM
    Ann Biol Clin (Paris); 1968; 26(10):1267-73. PubMed ID: 4973154
    [No Abstract]   [Full Text] [Related]  

  • 22. Relationships between the renal handling of DMPS and DMSA and the renal handling of mercury.
    Zalups RK; Bridges CC
    Chem Res Toxicol; 2012 Sep; 25(9):1825-38. PubMed ID: 22667351
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Meso-dimercaptosuccinic acid a chelating agent for the treatment of mercury and lead poisoning.
    Friedheim E; Crovi C; Wakker CH
    J Pharm Pharmacol; 1976 Sep; 28(9):711-2. PubMed ID: 10397
    [No Abstract]   [Full Text] [Related]  

  • 24. [DMSP treatment in acute sublimate (mercury chloride) poisoning].
    Nadig J; Knutti R; Hany A
    Schweiz Med Wochenschr; 1985 Apr; 115(15):507-11. PubMed ID: 3992234
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antioxidants and metallothionein levels in mercury-treated mice.
    Brandão R; Santos FW; Farina M; Zeni G; Bohrer D; Rocha JB; Nogueira CW
    Cell Biol Toxicol; 2006 Nov; 22(6):429-38. PubMed ID: 16964587
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Accumulation and removal of Hg203 in different regions of the rat brain.
    Butterworth RF; Gonce M; Barbeau A
    Can J Neurol Sci; 1978 Nov; 5(4):397-400. PubMed ID: 217517
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Meso-dimercaptosuccinic acid, a chelating agent for the treatment of mercury poisoning.
    Friedheim E; Corvi C
    J Pharm Pharmacol; 1975 Aug; 27(8):624-6. PubMed ID: 239185
    [No Abstract]   [Full Text] [Related]  

  • 28. Full recovery from a potentially lethal dose of mercuric chloride.
    Beasley DM; Schep LJ; Slaughter RJ; Temple WA; Michel JM
    J Med Toxicol; 2014 Mar; 10(1):40-4. PubMed ID: 23760886
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mercury poisoning: prevention by spironolactone.
    Selye H
    Science; 1970 Aug; 169(3947):775-6. PubMed ID: 5432573
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monoisoamyl and mono-n-hexyl meso-2,3-dimercaptosuccinate in mobilizing 203Hg retention in relation to age of rats and route of administration.
    Kostial K; Blanusa M; Piasek M; Prester L; Jones MM; Singh PK
    J Appl Toxicol; 1995; 15(3):201-6. PubMed ID: 7560740
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Renal mercury content in HgCl2-induced acute renal failure in furosemide/saline-protected and nonprotected rats.
    Brunner FP; de Rougemont D; Robbiani M; Seiler H; Thiel G
    Nephron; 1985; 41(1):94-9. PubMed ID: 4033846
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute mercury intoxication and use of chelating agents.
    Boscolo M; Antonucci S; Volpe AR; Carmignani M; Di Gioacchino M
    J Biol Regul Homeost Agents; 2009; 23(4):217-23. PubMed ID: 20003760
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of dimercaptosuccinic acid on the excretion and distribution of mercury in rats and mice treated with mercuric chloride and methylmercury chloride.
    Magos L
    Br J Pharmacol; 1976 Apr; 56(4):479-84. PubMed ID: 1260228
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative effects of chelating agents on distribution, excretion, and renal toxicity of inorganic mercury in rats.
    Kojima S; Shimada H; Kiyozumi M
    Res Commun Chem Pathol Pharmacol; 1989 Jun; 64(3):471-84. PubMed ID: 2781144
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Simultaneous administration of sodium selenite and mercuric chloride decreases efficacy of DMSA and DMPS in mercury elimination in rats.
    Juresa D; Blanusa M; Kostial K
    Toxicol Lett; 2005 Jan; 155(1):97-102. PubMed ID: 15585364
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chelation in metal intoxication: effect of thiol chelators on renal cytosolic mercury.
    Tandon SK; Khandelwal S; Behari JR
    Z Gesamte Hyg; 1986 Sep; 32(9):540-1. PubMed ID: 3798979
    [No Abstract]   [Full Text] [Related]  

  • 37. Structural requirements for chelate antidotal efficacy in acute antimony(III) intoxication.
    Basinger MA; Jones MM
    Res Commun Chem Pathol Pharmacol; 1981 May; 32(2):355-63. PubMed ID: 6264554
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of chelators on mercury, iron, and lead neurotoxicity in cortical culture.
    Rush T; Hjelmhaug J; Lobner D
    Neurotoxicology; 2009 Jan; 30(1):47-51. PubMed ID: 19027035
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mercury elimination with oral DMPS, DMSA, vitamin C, and glutathione: an observational clinical review.
    Muran PJ
    Altern Ther Health Med; 2006; 12(3):70-5. PubMed ID: 16708769
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Utilization of renal slices to evaluate the efficacy of chelating agents for removing mercury from the kidney.
    Keith RL; Setiarahardjo I; Fernando Q; Aposhian HV; Gandolfi AJ
    Toxicology; 1997 Jan; 116(1-3):67-75. PubMed ID: 9020508
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.